Detail
| LncRNA Name | LINC00152 |
| Synonyms | CYTOR, C2orf59, LINC00152, NCRNA00152, MGC4677 |
| Region | GRCh38_2:87454781-87636740 Sequence |
| Ensembl | ENSG00000222041 |
| RefSeq | NR_024204 |
| Circulating | ✘ |
| Drug-resisitant | ✔ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | colorectal cancer |
| ICD-0-3 | C19.9 |
| Methods | Microarray, qPCR etc. |
| Sample | cell lines (CRC,HCT116,HT29), CRC tissues |
| Expression Pattern | up-regulated |
| Function Description | Residual CRC cell biological characteristics are modulated via LINC00152 silencing.LINC00152,which is known to regulate the cytoskel- eton, may also be involved in cell cycle regulation and DNA damage repair.LINC00152 is a potential oncogene which may be involved in various types of cancer. |
| Pubmed ID | 29541183 |
| Year | 2018 |
| Title | LINC00152 is a potential biomarker involved in the modulation of biological characteristics of residual colorectal cancer cells following chemoradiotherapy. |
| External Links |
| Links for LINC00152 | GenBank HGNC lncrnadb Noncode |
| Links for colorectal cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.